Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[MDMA (ecstasy): neuroendocrine and behavioral features].

Gilberto Gerra1, Amir Zaimovic, Gabriele Moi

  • 1Centro Studi Farmacotossicodipendenze, Servizio Tossicodipendenze, AUSL di Parma, Via Spalato 2, 43100 Parma. behpharm@tin.it

Annali Dell'Istituto Superiore Di Sanita
|March 21, 2003
PubMed
Summary

Ecstasy (MDMA) use causes long-lasting impairment in the brain's serotonin system, leading to persistent behavioral and cognitive deficits. These changes suggest potential long-term neurotoxicity and vulnerability to substance abuse.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peer Relationships and Psychosocial Difficulties in Adolescents: Evidence from a Clinical Pediatric Sample.

Journal of clinical medicine·2025
Same author

The Signalled Licking/Avoidance of Punishment (SLAP) Paradigm in Rats: Capacity for Insight Between Goal Conditioning and Signalling Contingencies.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2025
Same author

My personal goodbye to all the NBR community.

Neuroscience and biobehavioral reviews·2025
Same author

Impact of UNODC/WHO S-O-S (stop-overdose-safely) training on opioid overdose knowledge and attitudes among people at high or low risk of opioid overdose in Kazakhstan, Kyrgyzstan, Tajikistan and Ukraine.

Harm reduction journal·2025
Same author

Can we target insulin signalling for cognition therapeutics?

Expert opinion on therapeutic targets·2024
Same author

Mental health interventions in an Italian prison: the Parma integrated approach.

International journal of prisoner health·2024

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Behavioral Science

Context:

  • Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is a recreational drug known for its psychoactive effects.
  • Studies indicate potential neurotoxic effects of MDMA on serotonin (5HT) and dopamine systems.
  • Behavioral changes in users include mood disorders, impulsivity, and cognitive deficits.

Purpose:

  • To investigate the long-term effects of ecstasy (MDMA) on the central nervous system.
  • To examine the persistence of neuroendocrine and behavioral changes following MDMA discontinuation.
  • To explore the potential for pre-existing vulnerabilities contributing to substance abuse.

Summary:

  • Long-lasting impairment of the serotonin (5HT) system is observed in animal models following MDMA exposure.

Related Experiment Videos

  • Behavioral conditioning and repeated use may be linked to MDMA's dopaminergic actions.
  • Human studies confirm serotonin system derangement via neuroendocrine challenges and brain imaging, with recent research suggesting dopaminergic system alterations.
  • Persistent behavioral and neuroendocrine changes months after MDMA cessation indicate potential lack of reversibility or pre-existing vulnerabilities.

    • Impact:

    • Findings suggest that MDMA use can lead to enduring neurobiological dysfunction.
    • The persistence of these changes highlights potential long-term health risks associated with ecstasy use.
    • Understanding these effects may inform strategies for preventing and treating substance abuse disorders.